Related references
Note: Only part of the references are listed.Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
Mengjing Cui et al.
FRONTIERS IN GENETICS (2022)
Development and verification of an immune-related gene pairs prognostic signature in ovarian cancer
Bao Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Construction and validation of an RNA-binding protein-associated prognostic model for colorectal cancer
Yandong Miao et al.
PEERJ (2021)
TCGA molecular subgroups of endometrial carcinoma in ovarian endometrioid carcinoma: A quantitative systematic review
Nicoletta D'Alessandris et al.
GYNECOLOGIC ONCOLOGY (2021)
Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment
Jianlei Bi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Variant PNLDC1, Defective piRNA Processing, and Azoospermia
L. Nagirnaja et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
CACNA1C is a prognostic predictor for patients with ovarian cancer
Xiaohan Chang et al.
JOURNAL OF OVARIAN RESEARCH (2021)
RNA Binding Protein-Based Model for Prognostic Prediction of Colorectal Cancer
Ting Li et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Zucchini consensus motifs determine the mechanism of pre-piRNA production
Natsuko Izumi et al.
NATURE (2020)
A Novel Six-Gene Signature for Prognosis Prediction in Ovarian Cancer
Xin Pan et al.
FRONTIERS IN GENETICS (2020)
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study
Matteo Dugo et al.
GENES (2019)
A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
Yixin Liu et al.
FRONTIERS IN ONCOLOGY (2019)
High Expression Levels of AGGF1 and MFAP4 Predict Primary Platinum-Based Chemoresistance and are Associated with Adverse Prognosis in Patients with Serous Ovarian Cancer
Haiyue Zhao et al.
JOURNAL OF CANCER (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Whole genome sequencing analysis for cancer genomics and precision medicine
Hidewaki Nakagawa et al.
CANCER SCIENCE (2018)
Development of SGLT1 and SGLT2 inhibitors
Timo Rieg et al.
DIABETOLOGIA (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Pancreatic cancer survival analysis defines a signature that predicts outcome
Pichai Raman et al.
PLOS ONE (2018)
Black bean peptides inhibit glucose uptake in Caco-2 adenocarcinoma cells by blocking the expression and translocation pathway of glucose transporters
Luis Mojica et al.
TOXICOLOGY REPORTS (2018)
Seven Genes Based Novel Signature Predicts Clinical Outcome and Platinum Sensitivity of High Grade IIIc Serous Ovarian Carcinoma
Gang Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Real-world evidence in the treatment of ovarian cancer
E. A. Eisenhauer
ANNALS OF ONCOLOGY (2017)
FLIPL is critical for aerobic glycolysis in hepatocellular carcinoma
Shixiong Lei et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
A novel gene expression-based prognostic scoring system to predict survival in gastric cancer
Pin Wang et al.
ONCOTARGET (2016)
Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors
A. C. V. Krepischi et al.
MOLECULAR CYTOGENETICS (2016)
Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms
Elisa Specht et al.
HISTOPATHOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients
Chih-Yang Wang et al.
PLOS ONE (2015)
Platinum resistant ovarian cancer: What is it, who to treat and how to measure benefit?
Alison Davis et al.
GYNECOLOGIC ONCOLOGY (2014)
The Role of SGLT1 and GLUT2 in Intestinal Glucose Transport and Sensing
Pia V. Roeder et al.
PLOS ONE (2014)
Synemin: an evolving role in tumor growth and progression
Shailendra Kapoor
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)
A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values
Guang-Zhi Jin et al.
BMC CANCER (2013)
The SLC2 (GLUT) family of membrane transporters
Mike Mueckler et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
MAP17 and SGLT1 Protein Expression Levels as Prognostic Markers for Cervical Tumor Patient Survival
Marco Perez et al.
PLOS ONE (2013)
EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors
Jiangong Ren et al.
PROSTATE (2013)
Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma
Bingquan Lai et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
GDF3 inhibits the growth of breast cancer cells and promotes the apoptosis induced by Taxol
Qiang Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Chemotherapy in epithelial ovarian cancer
Sandro Pignata et al.
CANCER LETTERS (2011)
Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosis
Gui Fang Guo et al.
MEDICAL ONCOLOGY (2011)
PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data
Chris D. Greenman et al.
BIOSTATISTICS (2010)
Overcoming platinum resistance in ovarian carcinoma
Koji Matsuo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma
Nobuyuki Ehira et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Intermediate filament dynamics and breast cancer: Aberrant promoter methylation of the Synemin gene is associated with early tumor relapse
E. Noetzel et al.
ONCOGENE (2010)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer
Tomas Bonome et al.
CANCER RESEARCH (2008)
Seizure 6-like (SEZ6L) gene and risk for lung cancer
Ivan P. Gorlov et al.
CANCER RESEARCH (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Receiver-operating characteristic curves and likelihood ratios: improvements over traditional methods for the evaluation and application of veterinary clinical pathology tests
Ian A. Gardner et al.
VETERINARY CLINICAL PATHOLOGY (2006)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group trial
M Markman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
Automated subcellular localization and quantification of protein expression in tissue microarrays
RL Camp et al.
NATURE MEDICINE (2002)
Share Paper
